Concurrent Investment Advisors’s 4D Molecular Therapeutics FDMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-17,325
Closed -$552K 962
2024
Q1
$552K Buy
+17,325
New +$552K 0.02% 516